1. Practice points in gynecardiology: Abnormal uterine bleeding in premenopausal women taking oral anticoagulant or antiplatelet therapy
- Author
-
Lian G. Ulrich, Janneke P.C. Grutters, Karin Schenck-Gustafsson, Mia von Euler, Marlies Y. Bongers, Angela H.E.M. Maas, Herbert J. A. Rolden, MUMC+: MA Medische Staf Obstetrie Gynaecologie (9), Obstetrie & Gynaecologie, Health Services Research, RS: GROW - Developmental Biology, and RS: GROW - R4 - Reproductive and Perinatal Medicine
- Subjects
Adult ,medicine.medical_specialty ,Vascular damage Radboud Institute for Health Sciences [Radboudumc 16] ,Cardiology ,Abnormal uterine bleeding ,Intrauterine device ,General Biochemistry, Genetics and Molecular Biology ,Antithrombotic ,medicine ,Humans ,Intensive care medicine ,Menorrhagia ,Geriatrics ,Uterine Hemorrhage ,business.industry ,Antiplatelet therapy ,Gynecardiology ,Anticoagulants ,Obstetrics and Gynecology ,Atrial fibrillation ,medicine.disease ,Thrombosis ,Contraception ,Premenopause ,Gynecology ,Family planning ,Urological cancers Radboud Institute for Health Sciences [Radboudumc 15] ,Physical therapy ,Platelet aggregation inhibitor ,Female ,Interdisciplinary Communication ,business ,Platelet Aggregation Inhibitors ,Novel oral anticoagulants - Abstract
Item does not contain fulltext A growing number of premenopausal women are currently using antithrombotic and/or (dual) antiplatelet therapy for various cardiovascular indications. These may induce or exacerbate abnormal uterine bleeding and more awareness and knowledge among prescribers is required. Heavy and irregular menstrual bleeding is common in women in their forties and may have a variety of underlying causes that require different treatment options. Thus using anticoagulants in premenopausal women demands specific expertise and close collaboration between cardiovascular physicians and gynecologists. In this article we summarize the scope of the problem and provide practical recommendations for the care for young women taking anticoagulants and/or (dual) antiplatelet therapy. We also recommend that more safety data on uterine bleeding with novel anticoagulants in premenopausal women should be obtained.
- Published
- 2015